ATE152907T1 - Ophtalmische suspensionen - Google Patents

Ophtalmische suspensionen

Info

Publication number
ATE152907T1
ATE152907T1 AT91912359T AT91912359T ATE152907T1 AT E152907 T1 ATE152907 T1 AT E152907T1 AT 91912359 T AT91912359 T AT 91912359T AT 91912359 T AT91912359 T AT 91912359T AT E152907 T1 ATE152907 T1 AT E152907T1
Authority
AT
Austria
Prior art keywords
suspension
weight
eye
ophthalmic medicament
mosm
Prior art date
Application number
AT91912359T
Other languages
English (en)
Inventor
Jeffery P Davis
Santosh Kumar Chandraskaran
Yansheng Su
Roy D Archibald
Joseph R Robinson
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24172504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE152907(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of ATE152907T1 publication Critical patent/ATE152907T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91912359T 1990-06-27 1991-06-25 Ophtalmische suspensionen ATE152907T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/544,518 US5192535A (en) 1988-02-08 1990-06-27 Ophthalmic suspensions

Publications (1)

Publication Number Publication Date
ATE152907T1 true ATE152907T1 (de) 1997-05-15

Family

ID=24172504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912359T ATE152907T1 (de) 1990-06-27 1991-06-25 Ophtalmische suspensionen

Country Status (13)

Country Link
US (1) US5192535A (de)
EP (1) EP0536255B1 (de)
JP (1) JP3237118B2 (de)
AT (1) ATE152907T1 (de)
AU (1) AU8103991A (de)
CA (1) CA2086121C (de)
DE (1) DE69126134T2 (de)
DK (1) DK0536255T3 (de)
ES (1) ES2103815T3 (de)
GR (1) GR3023915T3 (de)
NZ (1) NZ238756A (de)
WO (1) WO1992000044A1 (de)
ZA (1) ZA914971B (de)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461081A (en) * 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5366985A (en) * 1991-03-27 1994-11-22 Senju Pharmaceutical Co., Ltd. Method for preparation of an aqueous suspension
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
WO1994001108A1 (en) * 1992-07-02 1994-01-20 Theratech, Inc. Controlled release pilocarpine delivery system
US5661171A (en) * 1992-07-02 1997-08-26 Oramed, Inc. Controlled release pilocarpine delivery system
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
CA2153990A1 (en) * 1993-01-21 1994-08-04 Julio Mariano Fernandez Microparticle switching devices
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
EP0664699A1 (de) * 1993-08-13 1995-08-02 Vitaphore Corporation Arzneimittelabgabesystem auf der Basis von Hydrogelmikrokugeln
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
AU692852B2 (en) 1994-03-04 1998-06-18 University Of Washington Block and graft copolymers and methods relating thereto
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US6309630B1 (en) 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
US5827835A (en) * 1994-08-30 1998-10-27 Alcon Laboratories, Inc. Thermally-gelling emulsions
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) * 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
US6045557A (en) * 1995-11-10 2000-04-04 Baxter International Inc. Delivery catheter and method for positioning an intraluminal graft
US5968068A (en) * 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
CN100408100C (zh) 1997-07-29 2008-08-06 阿尔康实验室公司 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
US6277365B1 (en) 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
AU1388999A (en) * 1997-12-16 1999-07-05 Alcon Laboratories, Inc. The use of nitric oxide generations for the treatment of dry eye disorders
AU2479099A (en) * 1998-01-28 1999-08-16 Seatrace Pharmaceuticals, Inc. Topical vasodilatory gel composition and methods of use and production
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20080102121A1 (en) * 1998-11-02 2008-05-01 Elan Pharma International Limited Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001032181A2 (en) 1999-11-01 2001-05-10 Alcon Universal Ltd. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
HUP0001769A2 (hu) * 2000-05-04 2002-01-28 dr. Kahán Ilona Molnárné Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
ES2225573T3 (es) 2000-07-28 2005-03-16 Alcon, Inc Composiciones farmaceuticas que contienen tobramicina y goma xantana.
US20030195179A1 (en) * 2000-08-25 2003-10-16 Shirou Sawa Aqueous suspension preparations
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
AU2720602A (en) * 2000-11-08 2002-05-21 Bio Concept Lab Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
JP5258139B2 (ja) * 2000-11-08 2013-08-07 エフエックスエス・ベンチャーズ・エルエルシー ビタミンｂの形態を含有する改良した眼科用およびコンタクトレンズ用溶液
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20030220376A1 (en) * 2001-08-10 2003-11-27 Pharmacia Corporation Methods for treating carbonic anhydrase mediated disorders
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US20030099294A1 (en) * 2001-11-27 2003-05-29 Limin Wang Picture level adaptive frame/field coding for digital video content
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
BR0307898A (pt) * 2002-02-22 2004-12-07 Pharmacia Corp Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
JP2005529122A (ja) * 2002-04-25 2005-09-29 ラピッドヒール インコーポレイティッド 創傷治癒のための増殖因子送達システムならびに炎症および疾患の予防方法
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
AU2003256381A1 (en) * 2002-07-03 2004-01-23 Pericor Science, Inc Compositions of hyaluronic acid and methods of use
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US8512727B2 (en) 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) * 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN1852700A (zh) * 2003-09-23 2006-10-25 爱尔康公司 曲安奈德和醋酸阿奈可他注射用制剂
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
US20080139652A1 (en) 2003-11-07 2008-06-12 Yusuke Sakai Pharmaceutical Composition Containing Prostaglandin
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
EP2388078B1 (de) 2004-11-18 2013-03-20 3M Innovative Properties Co. Verfahren zum Kontaktbeschichten einer Mikronadelanordnung
JP4927751B2 (ja) * 2004-11-18 2012-05-09 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルアレイのコーティング方法
CN101060882B (zh) 2004-11-18 2010-06-16 3M创新有限公司 微针阵列施放器和保持器
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
AU2005306422A1 (en) 2004-11-18 2006-05-26 3M Innovative Properties Company Low-profile microneedle array applicator
US7236693B2 (en) 2005-03-22 2007-06-26 Globaltec Fireplaces, Inc. Flame simulator for use in an electric heater
WO2006104760A2 (en) * 2005-03-25 2006-10-05 Allergan, Inc. OPHTHALMIC COMPOSITIONS COMPRISING dDC
EP1973525B1 (de) * 2005-12-05 2014-04-30 RBA Pharma Inc. Emulsionshaltige medizinische artikel
US9119945B2 (en) * 2006-04-20 2015-09-01 3M Innovative Properties Company Device for applying a microneedle array
US20070281894A1 (en) * 2006-06-05 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
WO2009135135A2 (en) * 2008-05-01 2009-11-05 Chia Soo Fibromodulin formulation for reducing corneal scarring
US20090286826A1 (en) * 2008-05-19 2009-11-19 Francisco Javier Galan Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer
DE102008059201A1 (de) * 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
US8778999B2 (en) * 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
US20170128481A9 (en) 2009-03-06 2017-05-11 Insite Vision Corporation Ocular treatment with reduced intraocular pressure
US10980818B2 (en) 2009-03-06 2021-04-20 Sun Pharma Global Fze Methods for treating ocular inflammatory diseases
US10201548B2 (en) 2009-03-06 2019-02-12 Sun Pharma Global Fze Methods for treating ocular inflammatory diseases
WO2011057209A1 (en) * 2009-11-06 2011-05-12 Qlt, Inc. Acidic ophthalmic formulations
AU2010326099B2 (en) 2009-12-03 2013-03-07 Novartis Ag Carboxyvinyl polymer-container nanoparticle suspensions
US20130023575A1 (en) * 2011-07-22 2013-01-24 Kamran Hosseini Compositions and methods for the treatment of ocular surface allergies
EP2758031A1 (de) 2011-09-22 2014-07-30 Bausch & Lomb Incorporated Ophthalmische gelzusammensetzungen
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
ES2896336T3 (es) 2011-12-07 2022-02-24 Allergan Inc Suministro eficiente de lípidos a película lagrimal humana usando un sistema de emulsión sensible a sales
CN104602670A (zh) 2012-08-31 2015-05-06 博士伦公司 含有ω-3 脂肪酸的眼用组合物
US9950002B2 (en) 2013-09-16 2018-04-24 Regents Of The University Of Minnesota Nanoparticles/theranostic vehicles
PL4082531T3 (pl) 2015-01-26 2024-04-08 Bausch & Lomb Incorporated Oftalmiczna kompozycja zawiesinowa
AU2016298951B2 (en) 2015-07-27 2019-07-04 Catacore, Inc Compositions for the treatment of cataracts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
WO1984004680A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic gel
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
EP0501523B1 (de) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhäsive Mittel
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US4820737A (en) * 1987-02-17 1989-04-11 University Of Iowa Research Foundation Lacrimal secretion stimulant (lss)
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions

Also Published As

Publication number Publication date
CA2086121C (en) 2001-11-20
JPH05508641A (ja) 1993-12-02
DE69126134D1 (de) 1997-06-19
US5192535A (en) 1993-03-09
ZA914971B (en) 1992-09-30
DE69126134T2 (de) 1997-10-09
WO1992000044A1 (en) 1992-01-09
GR3023915T3 (en) 1997-09-30
EP0536255A4 (en) 1993-07-07
CA2086121A1 (en) 1991-12-28
AU8103991A (en) 1992-01-23
EP0536255B1 (de) 1997-05-14
ES2103815T3 (es) 1997-10-01
NZ238756A (en) 1992-11-25
EP0536255A1 (de) 1993-04-14
JP3237118B2 (ja) 2001-12-10
DK0536255T3 (da) 1997-08-25

Similar Documents

Publication Publication Date Title
ATE152907T1 (de) Ophtalmische suspensionen
DE68907545D1 (de) Ophthalmische suspensionen.
ATE192332T1 (de) Alkalische ophthalmische suspensionen
CA2086120A1 (en) Topical ophthalmic suspensions
ATE205079T1 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
KR850003327A (ko) 물 분리제
ATE60997T1 (de) Vernetzte poroese polymere fuer eine kontrollierte wirkstoffabgabe.
US4592752A (en) Non-optical corneal drug delivery
KR920011478A (ko) 안과용 미소구
Durrani et al. A novel ocular delivery system for phenylephrine hydrochloride

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time